Cargando…

APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

Detalles Bibliográficos
Autores principales:	You, Hong, Ma, Xiong, Efe, Cumali, Wang, Guiqiang, Jeong, Sook-Hyang, Abe, Kazumichi, Duan, Weijia, Chen, Sha, Kong, Yuanyuan, Zhang, Dong, Wei, Lai, Wang, Fu-Sheng, Lin, Han-Chieh, Yang, Jin Mo, Tanwandee, Tawesak, Gani, Rino A., Payawal, Diana A., Sharma, Barjesh C., Hou, Jinlin, Yokosuka, Osamu, Dokmeci, A. Kadir, Crawford, Darrell, Kao, Jia-Horng, Piratvisuth, Teerha, Suh, Dong Jin, Lesmana, Laurentius A., Sollano, Jose, Lau, George, Sarin, Shiv K., Omata, Masao, Tanaka, Atsushi, Jia, Jidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843914/ https://www.ncbi.nlm.nih.gov/pubmed/35119627 http://dx.doi.org/10.1007/s12072-021-10276-6

Ejemplares similares

APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19
por: Shiina, Shuichiro, et al.
Publicado: (2020)

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2021)

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2022)

APASL consensus statements and recommendation on treatment of hepatitis C
por: Omata, Masao, et al.
Publicado: (2016)

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
por: Omata, Masao, et al.
Publicado: (2016)

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
por: Kanda, Tatsuo, et al.
Publicado: (2018)

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
por: Kanda, Tatsuo, et al.
Publicado: (2019)

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
por: Sarin, Shiv Kumar, et al.
Publicado: (2020)

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
por: Omata, Masao, et al.
Publicado: (2017)

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
por: Sarin, Shiv Kumar, et al.
Publicado: (2019)

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
por: Sarin, Shiv Kumar, et al.
Publicado: (2019)

Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
por: George, Jacob, et al.
Publicado: (2023)

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
por: Wang, Guiqiang, et al.
Publicado: (2021)

An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
por: Charlton, Michael R., et al.
Publicado: (2020)

Non‐alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single‐center experience
por: Lesmana, Cosmas R A, et al.
Publicado: (2017)

Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study
por: Piratvisuth, Teerha, et al.
Publicado: (2021)

Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2020)

Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2022)

Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study
por: Teerasarntipan, Tongluk, et al.
Publicado: (2022)

Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
por: Malik, Juliane, et al.
Publicado: (2022)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
por: Piratvisuth, Teerha, et al.
Publicado: (2016)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
por: Piratvisuth, Teerha, et al.
Publicado: (2013)

Therapeutic Interventional Endoscopic Ultrasound Based on Rare Cases in Indonesia: A Single-Center Experience in Unselected Patients
por: Lesmana, Cosmas Rinaldi A., et al.
Publicado: (2017)

Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023)

Endoscopic Management Using Novel Haemostatic Agents for Immediate Bleeding during Endoscopic Retrograde Cholangio-Pancreatography
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2023)

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies
por: Piratvisuth, Teerha, et al.
Publicado: (2023)

APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review
por: Tan, Cher Heng, et al.
Publicado: (2011)

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Palliative Endoscopic Ultrasound Biliary Drainage for Advanced Malignant Biliary Obstruction: Should It Replace the Percutaneous Approach?
por: Lesmana, C. Rinaldi A., et al.
Publicado: (2019)

Abstracts of the 26th Annual Conference of APASL, February 15–19, 2017, Shanghai, China
Publicado: (2017)

Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2021)

Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
por: Thanapirom, Kessarin, et al.
Publicado: (2021)

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2019)

Comparison between Computer Tomography and Magnetic Resonance Imaging in the Diagnosis of Small Hepatocellular Carcinoma
por: Lertpipopmetha, Korn, et al.
Publicado: (2016)

Impact of Endoscopic Ultrasound Procedures in Various Pancreatobiliary Disorders in Indonesia Based on a Case Series in a Private Hospital
por: Lesmana, C. Rinaldi A., et al.
Publicado: (2015)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

A Comparison of Clinical Manifestations and Outcomes between Acute Sporadic Hepatitis A and Hepatitis E Infections in Thailand
por: Khongviwatsathien, Sirajuk, et al.
Publicado: (2023)

Abstracts of the 27th Annual Conference of APASL, March 14–18, 2018, New Delhi, India
Publicado: (2018)

Efficacy of Prothrombin Complex Concentrate Treatment in Patients with Liver Coagulopathy Who Underwent Various Invasive Hepatobiliary and Gastrointestinal Procedures
por: Lesmana, Cosmas Rinaldi A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8vgpdvar1fbm4vm14dpjtaij1v